Biogenerics | Generic Pharmaceutical Association

Biogenerics

White House Ignores Savings from Increasing Access to Generic Medicine

Press Release | March 3, 2010

GAO Report on Lack of Competition for Medicare Biotech Drugs Again Underscores Need for Congress to Act, GPhA Says

Press Release | March 1, 2010

GPhA Urges the White House and Congress to Heed Message of CCPM Health Care Reform Ad Campaign

Press Release | December 17, 2009

Senate HCR Bill Gratuitously Extends Biologic Monopolies: Lifts Brand Profits to New Heights At Consumer Expense

Press Release | November 19, 2009

GPhA Asks President Obama to Urge Congress to Strike Biogenerics from Health Care Reform if Provisions Are Not Substantially Altered

Press Release | October 28, 2009

New England Journal of Medicine Perspective Calls Upon President Obama to Encourage Congress to Adopt Exclusivity Periods for Biopharmaceuticals Similar to Those in Hatch-Waxman Act

Press Release | October 15, 2009

GPhA: Senator Hatch and Chairman Waxman Stress Important Role Generic Medicines Play in Strengthening Health Care System on 25th Anniversary of Hatch-Waxman Act

Press Release | September 18, 2009

GPhA: Obama Administration Says it Will Continue to Push for Seven Years of Market Exclusivity for Biogenerics

Press Release | September 17, 2009

GPhA Responds to House Energy and Commerce Committee Action on Biogenerics

Press Release | July 31, 2009

Generic Manufacturers Stated that Flawed Biogenerics Legislation Creates Ill-Advised Incentives for them to Produce Expensive Brand – Not Generic – Biotech Products

Press Release | July 22, 2009